Miracle Trial Preliminary Blinded CRc Rate of 40% in First 30 Patients Suggests Encouraging Early Results in Relapsed/Refractory AML HOUSTON, March 19, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc.

The treatment is known as 3D interstitial high-dose-rate brachytherapy, a technique that delivers radiation directly inside the tumour rather than from outside the body.

Miracle Trial Preliminary Blinded CRc Rate of 40% in First 30 Patients Suggests Encouraging Early Results in Relapsed/Refractory AML HOUSTON, March 19, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc.

In a new documentary, broadcaster Maxine Hughes gives an unfiltered account of what it’s like to experience cancer ...

A cancer diagnosis can be one of the most frightening moments in a person’s life. One of the first questions many people ask is how long they will live. This is a very natural question, but the answer ...

Company Served as Sponsor and Provided Operational Leadership for Study Conducted in Partnership with TGen and Virta ...

"Prevention and early detection remain some of the most powerful tools we have to reduce cancer risk in the future." ...

Paul, a liver cancer survivor, and his wife Emma share their journey of recovery, caregiving and finding balance in life ...

Physical and psychological recovery and beyond ...

Gastric cancer remains a major global health challenge, responsible for significant mortality worldwide. The human gut microbiome and its dysregulation, particularly involving Helicobacter pylori, ...

This year, students at The King's School in Sydney are starting lessons later on Wednesdays. The start of the usual day has ...

NAVI MUMBAI, MAHARASHTRA, INDIA, March 19, 2026 / EINPresswire.com / — Faresefursat.com, a travel services platform operated by PAYAKT PRIVATE LIMITED, has announced the introduction of a AI ...